Altium, IPC Education Foundation, and Arduino Announce Student Electronics Design Competition
8.9.2021 10:22:00 EEST | Business Wire | Press release
Altium LLC, the leading printed circuit board (PCB) software company, is partnering with the IPC Education Foundation (IPCEF) and Arduino to launch the first student electronics design challenge to engage, educate, and enhance printed circuit board (PCB) design capabilities while developing STEM solutions to environmental challenges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005457/en/
Upverter Education, a division of Altium, the IPC Education Foundation, and Arduino are partnering to create the first student design competition to engage, educate, and enhance students’ proficiencies in PCB design, with a focus on solving some of the world’s most pressing environmental challenges. (Photo: Altium LLC)
The Innovation for Environmental Change 2021 International Student Design Competition (#PCBeTheChange) engages student teams to help address common environmental concerns using Altium’s educational tools with Arduino hardware.
Teams from high schools and colleges will be using Altium’s Upverter Modular PCB design software and the Arduino Portenta H7 to create a prototype design that will improve the environment in each team’s respective local area. The teams will be challenged to tackle one or more environmental concerns, such as air pollution, water quality and solar energy capture.
As Lotte Nørregaard Andersen, Head of Arduino Education, elaborates, "At Arduino, we believe that it is very crucial to empower scientists of the future to address common challenges of our time using technology. We’re delighted to partner with Altium LLC and the IPC Education Foundation in the Innovation for Environmental Change 2021 International Student Design Competition; this competition really aligns with our goal of creating the next generation of STEM solutions."
Participating teams can enter the design challenge while harnessing Altium’s Upverter Education training modules plus the Upverter Modular tool. Altium features multiple educational initiatives designed to support high school STEM teachers and students, along with programs to support college students and industry professionals.
“Students learning electronics design can get a comprehensive overview of how to design their own hardware with guided training in easy-to-understand modules. We’re honored to support the next generation of electronics designers by providing the curriculum and tools students need for the contest,” adds Rea Callender, Vice President of Upverter Education.
Winning teams will be eligible to win cash prizes for each category: high school and college: $1500 (1st prize), $750 (2nd prize) and $500 (3rd prize), free access to IPC APEX EXPO in San Diego, CA from January 25-27, 2022 as well as virtual access to AltiumLive 2022 CONNECT, co-located alongside the IPC APEX EXPO at the San Diego Convention Center. Designs will be featured on display at the IPC Design Booth; awards will be presented at the IPC APEX EXPO STEM Outreach Event.
Charlene Gunter, Senior Director of IPCEF shares, “We believe that opportunities and experiences like this will allow students to gain awareness and access to the electronics manufacturing industry and in turn help them reach their career goals. This collaborative partnership with Altium, Upverter Education, and Arduino showcases our mutual goals of engaging and educating students in PCB design, and we look forward to seeing the creativity and solutions the teams will create.”
Open registration is available via Upverter Education for the design challenge beginning on Monday, August 16th and runs through Friday, October 1st; team designs must be received online by Friday, November 19th. Competition winners will be announced on Friday, December 17th, followed by virtual presentations for the first place, and runner-up entrants.
For more information, please contact Upverter.Education@altium.com.
About Altium
Altium, LLC (ASX:ALU) is a global software company headquartered in San Diego, California, accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.
About Upverter Education
Upverter Education, launched by Altium in September 2020, is addressing an important societal need by empowering STEM educators teaching engineering, electronics design, and robotics with free essential tools and classroom resources. The program has been honored with multiple awards, including the EdTech Breakthrough Award, for Best Engineering Learning Solution and the Gold STEVIE® American Business Award, further validating Altium’s innovative approach to supporting STEM education.
About IPC Education Foundation (IPCEF)
The IPC Education Foundation creates awareness of the careers the electronics manufacturing industry has to offer students in high school and college by providing them with opportunities to access people, courses, and knowledge through key programs: 1) The IPC Student Chapter program provides scholarships, industry-standard education, industry connections, and access to hands-on competitions, especially with the support of industry experts and professionals; 2) IPC Video Subscription Libraries provide access to industry-relevant content to students in high school and college, and 3) a variety of engagement initiatives like in-person/virtual events, webinars, and classroom activities.
About Arduino
Arduino is the leading open-source hardware and software company in the world. Born to provide an easy-to-use platform for anyone making interactive projects, Arduino has reached a growing community and adapted to new needs and challenges, branching out into products for IoT, wearables, 3D printing, and embedded environments. As of today, the Arduino community included approximately 30 million active users.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210908005457/en/
Contact information
Xenia Moore
Altium
Senior Manager of PR and Brand Communications
pr@altium.com
Sandy Gentry
IPC
Director, Brand Communications
sandygentry@ipc.org
Luisa Castiglioni
Arduino
PR Manager
press@arduino.cc
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom